PAR 2.13% 23.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-3225

  1. 200 Posts.
    lightbulb Created with Sketch. 383
    Thanks @Denial. I just had a look at my MRIs again and endplate changes don’t seem to be a part of my condition (facet joint OA - the facet joints are a little distant from the discs).

    Marvelling right now at the complete absence of any sensation of arthritic pain or impairment, 6 months after my second pentosan treatment. Less happy about my elbow, which got caught in an arm bar while grappling and something snapped. It would be a great candidate for looking at pentosan for pain treatment and tendon repair, but no way to access for that indication right now.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.